189 related articles for article (PubMed ID: 34188118)
1. Serine residues 726 and 780 have nonredundant roles regulating STAT5a activity in luminal breast cancer.
Woock AE; Grible JM; Olex AL; Harrell JC; Zot P; Idowu M; Clevenger CV
Sci Rep; 2021 Jun; 11(1):13506. PubMed ID: 34188118
[TBL] [Abstract][Full Text] [Related]
2. Prolactin Drives a Dynamic STAT5A/HDAC6/HMGN2 Cis-Regulatory Landscape Exploitable in ER+ Breast Cancer.
Craig JM; Turner TH; Harrell JC; Clevenger CV
Endocrinology; 2021 May; 162(5):. PubMed ID: 33589921
[TBL] [Abstract][Full Text] [Related]
3. Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism.
Tran TH; Utama FE; Lin J; Yang N; Sjolund AB; Ryder A; Johnson KJ; Neilson LM; Liu C; Brill KL; Rosenberg AL; Witkiewicz AK; Rui H
Cancer Res; 2010 Feb; 70(4):1711-21. PubMed ID: 20124477
[TBL] [Abstract][Full Text] [Related]
4. Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformation.
Friedbichler K; Kerenyi MA; Kovacic B; Li G; Hoelbl A; Yahiaoui S; Sexl V; Müllner EW; Fajmann S; Cerny-Reiterer S; Valent P; Beug H; Gouilleux F; Bunting KD; Moriggl R
Blood; 2010 Sep; 116(9):1548-58. PubMed ID: 20508164
[TBL] [Abstract][Full Text] [Related]
5. HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth.
Medler TR; Craig JM; Fiorillo AA; Feeney YB; Harrell JC; Clevenger CV
Mol Cancer Res; 2016 Oct; 14(10):994-1008. PubMed ID: 27358110
[TBL] [Abstract][Full Text] [Related]
6. Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells.
Fang F; Rycyzyn MA; Clevenger CV
Endocrinology; 2009 Apr; 150(4):1597-606. PubMed ID: 19036881
[TBL] [Abstract][Full Text] [Related]
7. The transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells.
Linher-Melville K; Singh G
BMC Cancer; 2014 Jun; 14():415. PubMed ID: 24913037
[TBL] [Abstract][Full Text] [Related]
8. STAT5 and prolactin participate in a positive autocrine feedback loop that promotes angiogenesis.
Yang X; Meyer K; Friedl A
J Biol Chem; 2013 Jul; 288(29):21184-21196. PubMed ID: 23729680
[TBL] [Abstract][Full Text] [Related]
9. Role of serine phosphorylation of Stat5a in prolactin-stimulated beta-casein gene expression.
Yamashita H; Nevalainen MT; Xu J; LeBaron MJ; Wagner KU; Erwin RA; Harmon JM; Hennighausen L; Kirken RA; Rui H
Mol Cell Endocrinol; 2001 Oct; 183(1-2):151-63. PubMed ID: 11604235
[TBL] [Abstract][Full Text] [Related]
10. Aberrantly high expression of the CUB and zona pellucida-like domain-containing protein 1 (CUZD1) in mammary epithelium leads to breast tumorigenesis.
Mapes J; Anandan L; Li Q; Neff A; Clevenger CV; Bagchi IC; Bagchi MK
J Biol Chem; 2018 Feb; 293(8):2850-2864. PubMed ID: 29321207
[TBL] [Abstract][Full Text] [Related]
11. Differential control of the phosphorylation state of proline-juxtaposed serine residues Ser725 of Stat5a and Ser730 of Stat5b in prolactin-sensitive cells.
Yamashita H; Xu J; Erwin RA; Farrar WL; Kirken RA; Rui H
J Biol Chem; 1998 Nov; 273(46):30218-24. PubMed ID: 9804779
[TBL] [Abstract][Full Text] [Related]
12. Stat5a serine phosphorylation. Serine 779 is constitutively phosphorylated in the mammary gland, and serine 725 phosphorylation influences prolactin-stimulated in vitro DNA binding activity.
Beuvink I; Hess D; Flotow H; Hofsteenge J; Groner B; Hynes NE
J Biol Chem; 2000 Apr; 275(14):10247-55. PubMed ID: 10744710
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation of Grb2: role in prolactin/epidermal growth factor cross talk in mammary epithelial cell growth and differentiation.
Haines E; Minoo P; Feng Z; Resalatpanah N; Nie XM; Campiglio M; Alvarez L; Cocolakis E; Ridha M; Di Fulvio M; Gomez-Cambronero J; Lebrun JJ; Ali S
Mol Cell Biol; 2009 May; 29(10):2505-20. PubMed ID: 19273609
[TBL] [Abstract][Full Text] [Related]
14. STAT5a activation mediates the epithelial to mesenchymal transition induced by oncogenic RhoA.
Benitah SA; Valerón PF; Rui H; Lacal JC
Mol Biol Cell; 2003 Jan; 14(1):40-53. PubMed ID: 12529425
[TBL] [Abstract][Full Text] [Related]
15. Signal transducer and activator of transcription (STAT)-5A and STAT5B differentially regulate human mammary carcinoma cell behavior.
Tang JZ; Zuo ZH; Kong XJ; Steiner M; Yin Z; Perry JK; Zhu T; Liu DX; Lobie PE
Endocrinology; 2010 Jan; 151(1):43-55. PubMed ID: 19966185
[TBL] [Abstract][Full Text] [Related]
16. Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition.
Sultan AS; Brim H; Sherif ZA
Cancer Sci; 2008 Feb; 99(2):272-9. PubMed ID: 18271926
[TBL] [Abstract][Full Text] [Related]
17. STAT5A is regulated by DNA damage via the tumor suppressor p53.
Mukhopadhyay UK; Cass J; Raptis L; Craig AW; Bourdeau V; Varma S; SenGupta S; Elliott BE; Ferbeyre G
Cytokine; 2016 Jun; 82():70-9. PubMed ID: 26876578
[TBL] [Abstract][Full Text] [Related]
18. Src family kinases interfere with dimerization of STAT5A through a phosphotyrosine-SH2 domain interaction.
Fahrenkamp D; de Leur HS; Küster A; Chatain N; Müller-Newen G
Cell Commun Signal; 2015 Feb; 13():10. PubMed ID: 25885255
[TBL] [Abstract][Full Text] [Related]
19. The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells.
Hou L; Xu B; Mohankumar KM; Goffin V; Perry JK; Lobie PE; Liu DX
Int J Oncol; 2012 Dec; 41(6):2285-95. PubMed ID: 23064471
[TBL] [Abstract][Full Text] [Related]
20. Signal transducer and activator of transcription 5a/b: biomarker and therapeutic target in prostate and breast cancer.
Koptyra M; Gupta S; Talati P; Nevalainen MT
Int J Biochem Cell Biol; 2011 Oct; 43(10):1417-21. PubMed ID: 21704724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
